Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)

ClinicalTrials.gov ID: NCT03377491

Public ClinicalTrials.gov record NCT03377491. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 3:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Gemcitabine and Nab-paclitaxel for Front-line Treatment of Locally-advanced Pancreatic Adenocarcinoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Brief Summary: The study is a prospective, randomized controlled phase III trial aimed to test the efficacy and safety of Tumor Treating Fields (TTFields) in combination with gemcitabine and nab-paclitaxel, for front line treatment of locally-advanced pancreatic adenocarcinoma.The device is an experimental, portable, battery operated device for chronic administration of alternating electric fields (termed TTFields or TTF) to the region of the malignant tumor, by means of surface, insulated electrode arrays.

Study identification

NCT ID
NCT03377491
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
NovoCure Ltd.
Industry
Enrollment
571 participants

Conditions and interventions

Interventions

Device · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 9, 2018
Primary completion
Oct 15, 2024
Completion
Oct 15, 2024
Last update posted
Jan 20, 2026

2018 – 2024

United States locations

U.S. sites
74
U.S. states
30
U.S. cities
69
Facility City State ZIP Site status
Grandview Medical Center, Cancer Center Birmingham Alabama 35243
Infirmary Cancer Care Mobile Alabama 36607
Banner MD Anderson Cancer Center Gilbert Arizona 85234
Arizona Oncology Associates, PC- HOPE - US Oncology Research Tucson Arizona 85711
University of Arizona Cancer Center Tucson Arizona 85724-5024
Pacific Cancer Medical Center Anaheim California 92801
Providence Medical Foundation Fullerton California 92835
Cedars-Sinai Medical Center Los Angeles California 90048
Dignity Health - Mercy Cancer Centers Sacramento California 95816
Sutter Cancer Center Sacramento Sacramento California 95816
Ridley-Tree Cancer Center Santa Barbara California 93105
Adventist Health St. Helena - Martin-O'Neil Cancer Center (MOCC) St. Helena California 94574
Associated Neurologists of Southern Connecticut, P.C. Milford Connecticut 06460
Boca Raton Regional Hospital, Lynn Cancer Institute Boca Raton Florida 33486
Cancer Specialist of North Florida Fleming Island Florida 32003
Florida Cancer Specialists & Research Institute - Colonial Office Fort Myers Florida 33905
Mayo Clinic Hospital - Florida Jacksonville Florida 32224
Mount Sinai Medical Center Miami Beach Florida 33140
AdventHealth Neuro Oncology Orlando Florida 32804
BRCR Medical Center INC Plantation Florida 33324
Florida Cancer Specialists St. Petersburg Florida 33705
Florida Hospital Tampa Tampa Florida 33613
Piedmont Cancer Institute Atlanta Georgia 30318
Illinois Cancer Specialist - US Oncology Research Arlington Heights Illinois 60005
Rush University Medical Center Chicago Illinois 60612
NorthShore University HealthSystem Evanston Illinois 60201
Loyola University Medical Center Maywood Illinois 60153
University of Kansas Medical Cancer Center Fairway Kansas 66205
Cotton O'Neil Cancer Center (Stormont-Vail Cancer Center) Topeka Kansas 66606
Saint Elizabeth Healthcare Edgewood Kentucky 41017
Norton Cancer Institute, Norton Healthcare Pavilion Louisville Kentucky 40202
Ochsner Medical Center New Orleans Louisiana 70121
Central Maine Medical Center, Clinical Research Department Lewiston Maine 04240
University of Maryland Comprehensive Cancer Center Baltimore Maryland 21201
Maryland Oncology Hematology, P.A - US Oncology Research Columbia Maryland 21044
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
UMass Memorial Medical Center Worcester Massachusetts 01605
Karmanos Cancer Institute Detroit Michigan 48201
Cancer and Hematology Centers of Western Michigan, PC Grand Rapids Michigan 49503
University of Minnesota Minneapolis Minnesota 55455
MidAmerica Division Kansas City Missouri 64132
Nebraska Methodist Hospital Omaha Nebraska 68114
OptumCare Cancer Care Las Vegas Nevada 89102
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89619
Renown Regional Medical Center & Renown Institute for Cancer Reno Nevada 89502
Astera Cancer Care East Brunswick New Jersey 08816
Kaleida Health Buffalo New York 14210
Bassett Medical Center Cooperstown New York 13326
New York Hospital Queens Flushing New York 11355
NYU Langone Arena Oncology Lake Success New York 11042
White Plains Hospital - Center for Cancer Care White Plains New York 10601
Novant Health Oncology Specialists Winston-Salem North Carolina 27103
Gabrail Cancer Research Center Canton Ohio 44718
Toledo Clinic Cancer Centers Toledo Ohio 44614
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104
Willamette Valley Cancer Institute and Research Center - US Oncology Research Eugene Oregon 97401
Geisinger Medical Center Danville Pennsylvania 17822
Vita Medical Associates, P.C. Fountain Hill Pennsylvania 18015
UT/Erlanger Oncology & Hematology Chattanooga Tennessee 37403
Tennessee Cancer Specialists Knoxville Tennessee 37909-1327
Tennessee Oncology Nashville Tennessee 37203
Texas Oncology - Beaumont Mamie McFaddin Ward Cancer Center - US Oncology Research Beaumont Texas 77702
Texas Oncology - Bedford - US Oncology Reasearch Bedford Texas 76022
Methodist Regional Cancer Center Dallas Texas 75203
Texas Oncology - Baylor - US Oncology Research Dallas Texas 75246
Texas Oncology - El Paso Cancer Treatment Center Gateway - US Oncology Research El Paso Texas 79915
Houston Methodist Cancer Center Houston Texas 77030
Baylor Scott and White Medical Center Temple Texas 76508
Texas Oncology - Tyler - US Oncology Research Tyler Texas 75702
Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care - US Oncology Research Roanoke Virginia 24014
Vista Oncology Inc PS Olympia Washington 98506
Virginia Mason Medical Center Seattle Washington 98101
Seattle Cancer Care Alliance Seattle Washington 98109
West Virginia University Cancer Institute Morgantown West Virginia 26506

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 125 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03377491, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 20, 2026 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03377491 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →